Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib (Q45353562)
Jump to navigation
Jump to search
scientific article published in December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib |
scientific article published in December 2012 |
Statements
1 reference
Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib (English)
1 reference
Toshihiro Fukushima
1 reference
Tomomi Sato
1 reference
Takuji Nakamura
1 reference
Haruka Iwao
1 reference
Akio Nakajima
1 reference
Miyuki Miki
1 reference
Tomoyuki Sakai
1 reference
Takafumi Kawanami
1 reference
Toshioki Sawaki
1 reference
Yoshimasa Fujita
1 reference
Masao Tanaka
1 reference
Yasufumi Masaki
1 reference
Toshiro Okazaki
1 reference
Hideo Nakajima
1 reference
Yoshiharu Motoo
1 reference
Hisanori Umehara
1 reference
1 December 2012
1 reference
1 reference
32
1 reference
12
1 reference
5437-5440
1 reference
Identifiers
1 reference